This study looked at the impact of Medicare Part D coverage gaps by examining drug discontinuation and reinitiation among Medicare beneficiaries using medications for cancer or rheumatoid arthritis. The study found that patients in the arthritis or cancer groups—28 and 21 percent,...

This study looked at the impact of Medicare Part D coverage gaps by examining drug discontinuation and reinitiation among Medicare beneficiaries using medications for cancer or rheumatoid arthritis. The study found that patients in the arthritis or cancer groups—28 and 21 percent,...

Using 2007 pharmacy claims for postmenopausal Medicare beneficiaries with osteoporosis, this study found medication discontinuation and out-of-pocket drug costs were highest for those enrolled in Medicare Part D plans with a coverage gap.

Using 2007 pharmacy claims for postmenopausal Medicare beneficiaries with osteoporosis, this study found medication discontinuation and out-of-pocket drug costs were highest for those enrolled in Medicare Part D plans with a coverage gap.

The Medicare Part D coverage gap has been associated with lower adherence and drug utilization and higher discontinuation. Because osteoporosis has a relatively high prevalence among Medicare-eligible postmenopausal women, we examined changes in utilization of osteoporosis medications during...